Intraoperative ICG-Fluorescence Imaging of Lymph Nodes in Robot-Assisted Radical Cystectomy in Patients with Bladder Cancer

Introduction. Bladder cancer dominates among global health problems. Radical cystectomy is the recognized standard of care for muscle-invasive bladder cancer with bilateral pelvic lymphadenectomy as a mandatory step in the surgical procedure. The concept of sentinel lymph nodes, acting as a barrier to the spread of malignant process, can be beneficial in terms of reducing the extent of pelvic lymphadenectomy. Intraoperative imaging using indocyanine green now appears to be a contemporary and relevant method for intraoperative imaging of sentinel lymph nodes. Materials and methods. A study involving 28 patients diagnosed with bladder cancer was carried out at the clinic of the Bashkir State Medical University. All patients underwent robot-assisted radical cystectomy with intracorporeal formation of a heterotopic neobladder using Bricker technique. At the stage of pelvic lymphadenectomy, the isolated lymph nodes were evaluated and intraoperative ICG-fluorescence was performed. All lymph nodes obtained were examined microscopically and the results were interpreted taking into account the intraoperative diagnosis. Results and discussion. Intraoperative ICG fluorescence identified sentinel lymph nodes in 7 of 9 patients (77.8%, p < 0.05), with sensitivity equal to 77.8%, p < 0.05 and specificity — 87.5%, p < 0.05. Conclusion. The results proved a high reliability of the method of intraoperative lymph nodes imaging with indocyanine green in patients with muscle-invasive bladder cancer. Fluorescence navigation in cancer surgery opens up new opportunities for improving perioperative outcomes and reducing complications.

1. World Health Organization. International Agency for Research on Cancer. The Global Cancer Observatory. (December, 2020). Bladder Source: Globocan 2020; [cited 2022 Dec 18]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/30-Bladder-fact-sheet.pdf

2. Trifanescu O.G., Gales L.N., Paun M.A., Motas N., Marinescu S.A., Virtosu I., et al. Long-term outcome of patients with stage II and III muscle-invasive urothelial bladder cancer after multimodality approach. Which Is the best option? Medicina (Kaunas). 2022;59(1):50. DOI: 10.3390/medicina59010050

3. Bochner B.H., Dalbagni G., Marzouk K.H., Sjoberg D.D., Lee J., Donat S.M., et al. Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: oncologic outcomes. Eur Urol. 2018;74(4):465–71. DOI: 10.1016/j.eururo.2018.04.030

4. Pavlov V.N., Urmantsev M.F., Bakeev M.R. The success of robotassisted cystectomy in the treatment of muscle-invasive bladder cancer. Cancer Urology. 2022;18(2):123–8 (In Russ.). DOI: 10.17650/17269776-202218-2-123-128

5. Pavlov V.N., Urmantsev M.F., Yudina Yu.B., Bakeev M.R. A place of robot-assisted cystectomy in treatment of muscle-invasive bladder cancer. Urologiia. 2021;6:141–4 (In Russ.). DOI: 10.18565/urology.2021.6.141-144

6. Zamboni S., Soria F., Mathieu R., Xylinas E., Abufaraj M., Andrea D.D., et al. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU Int. 2019;124(4):656–64. DOI: 10.1111/bju.14791

7. Sung H.H., Lerner S.P. Utility of lymphadenectomy in bladder cancer: where do we stand? Curr Opin Urol. 2020;30(3):407–14. DOI: 10.1097/MOU.0000000000000750

8. Qi W., Zhong M., Jiang N., Zhou Y., Lv G., Li R., et al. Which lymph node dissection template is optimal for radical cystectomy? A systematic review and Bayesian network meta-analysis. Front Oncol. 2022;12:986150. DOI: 10.3389/fonc.2022.986150

9. Małkiewicz B., Kiełb P., Gurwin A., Knecht K., Wilk K., Dobruch J., et al. The usefulness of lymphadenectomy in bladder cancer-current status. Medicina (Kaunas). 2021;57(5):415. DOI: 10.3390/medicina57050415

10. Rietbergen D.D.D., van Gennep E.J., KleinJan G.H., Donswijk M., Valdés Olmos R.A., van Rhijn B.W., et al. Evaluation of the hybrid tracer Indocyanine Green — 99m Tc-nanocolloid for sentinel node biopsy in bladder cancer — a prospective pilot study. Clin Nucl Med. 2022;47(9):774–80. DOI: 10.1097/RLU.0000000000004301

11. Piwkowski C., Gabryel P., Gąsiorowskia L., Zieliński P., Murawa D., Roszak M., et al. Indocyanine green fluorescence in the assessment of the quality of the pedicled intercostal muscle flap: a pilot study. Eur J Cardiothorac Surg. 2013;44(1):e77–81. DOI: 10.1093/ejcts/ezt102

12. Deng J., Hu W., Li Y., Xiong K., Yue T., Lai X., et al. Meta analysis of indocyanine green fluorescence in patients undergoing laparoscopic colorectal cancer surgery. Front Oncol. 2022;12:1010122. DOI: 10.3389/fonc.2022.1010122

13. Mastronardi M., Fracon S., Scomersi S., Fezzi M., Bortul M. Role of qualitative and quantitative indocyanine green angiography to assess mastectomy skin flaps perfusion in nipple/skin-sparing and skinreducing mastectomies with implant-based breast reconstruction. Breast J. 2022;2022:5142100. DOI: 10.1155/2022/5142100

14. Lee Y.J., van den Berg N.S., Orosco R.K., Rosenthal E.L., Sorger J.M. A narrative review of fluorescence imaging in robotic-assisted surgery. Laparosc Surg. 2021;5:31. DOI: 10.21037/ls-20-98

15. Zhu W., Xiong S., Wu Y., Zhang D., Huang C., Hao H., et al. Indocyanine green fluorescence imaging for laparoscopic complex upper urinary tract reconstructions: a comparative study. Transl Androl Urol. 2021;10(3):1071–9. DOI: 10.21037/tau-20-1261

16. Polom W., Migaczewski M., Skokowski J., Swierblewski M., Cwalinski T., Kalinowski L., et al. Multispectral imaging using fluorescent properties of Indocyanine Green and Methylene Blue in colorectal surgery-initial experience. J Clin Med. 2022;11(2):368. DOI: 10.3390/jcm11020368

17. Huang B.W., Wang J., Zhang P., Li Z., Bi S.C., Wang Q., et al. Application of indocyanine green in complex upper urinary tract repair surgery. Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52(4):651–6. [Chinese] DOI: 10.19723/j.issn.1671-167X.2020.04.010

18. Polom W., Markuszewski M., Cytawa W., Czapiewski P., Lass P., Matuszewski M. Fluorescent versus radioguided lymph node mapping in bladder cancer. Clin Genitourin Cancer. 2017;15(3):e405–9. DOI: 10.1016/j.clgc.2016.11.007

19. Sinha A., West A., Hayes J., Teoh J., Decaestecker K., Vasdev N. Methods of sentinel lymph node detection and management in urinary bladder cancer-a narrative review. Curr Oncol. 2022;29(3):1335–48. DOI: 10.3390/curroncol29030114

20. Ramírez Backhaus M., Calatrava-Fons A., Gómez-Ferrer Á., ColladoSerra A., Domínguez-Escrig J.L., Bertolo R., et al. ICG lymphography and fluorescence in pelvic lymphadenectomy for bladder and prostate cancer. Arch Esp Urol. 2019;72(8):831–41. PMID: 31579042

21. Pavlov V.N., Safiullin R.I., Urmantsev M.F., Abdrakhimov R.V., Denejko A.S., Imelbaeva A.G. Method of robot-assisted radical cystectomy in patients with bladder cancer: Russian Federation patent 2718279 C1. 2019 July 30. (In Russ.)

22. Roth B., Wissmeyer M.P., Zehnder P., Birkhäuser F.D., Thalmann G.N., Krause T.M., et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol. 2010;57(2):205–11. DOI: 10.1016/j.eururo.2009.10.026

23. Inoue S., Shiina H., Mitsui Y., Yasumoto H., Matsubara A., Igawa M. Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green. Can Urol Assoc J. 2013;7(5– 6):E322–8. DOI: 10.5489/cuaj.12096

24. Schaafsma B.E., Verbeek F.P., Elzevier H.W., Tummers Q.R., van der Vorst J.R., Frangioni J.V., et al. Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging. J Surg Oncol. 2014;110(7):845–50. DOI: 10.1002/jso.23740

25. Manny T.B., Hemal A.K. Fluorescence-enhanced robotic radical cystectomy using unconjugated indocyanine green for pelvic lymphangiography, tumor marking, and mesenteric angiography: the initial clinical experience. Urology. 2014;83(4):824–9. DOI: 10.1016/j.urology.2013.11.042

26. Ito K., Takahashi T., Kanno T., Okada T., Higashi Y., Yamada H. Indocyanine green fluorescence-guided partial cystectomy and pelvic lymphadenectomy for urachal carcinoma. J Endourol Case Rep. 2020;6(4):275–7. DOI: 10.1089/cren.2020.0025

27. Packiam V.T., Tsivian M., Boorjian S.A. The evolving role of lymphadenectomy for bladder cancer: why, when, and how. Transl Androl Urol. 2020;9(6):3082–93. DOI: 10.21037/tau.2019.06.01

28. van Manen L., Handgraaf H.J.M., Diana M., Dijkstra J., Ishizawa T., Vahrmeijer A.L., et al. A practical guide for the use of indocyanine green and methylene blue in fluorescence-guided abdominal surgery. J Surg Oncol. 2018;118(2):283–300. DOI: 10.1002/jso.25105